Sen. Susan M. Collins sold Biogen (BIIB)
Sen. Susan M. Collins (R-ME) · $1K–$15K · traded Mar 27, 2014
Got money from this company’s PAC
Biogen’s PAC gave $2K to Collins’s campaign in the 2025–26 election cycle. See it on FEC.gov ↗
Company PACs are funded by employees, not the company itself, and give to many members of both parties. A donation doesn’t mean the trade was connected.
- Transaction
- Sold (partial)
- Amount
- $1K–$15K
- Owner
- Spouse
- Traded
- Mar 27, 2014
- Disclosed
- Apr 1, 2014
- Days to disclose
- 5
- Asset type
- Stock
- As filed
- Biogen Idec Inc. (NASDAQ)
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
- Apr 1, 2014$1K–$15K
$1K–$15K · Traded Mar 27, 2014 · disclosed Apr 1, 2014 · Spouse
- Apr 1, 2014$1K–$15K
Sold (partial) Celgene Corporation (NASDAQ) CELG
$1K–$15K · Traded Mar 27, 2014 · disclosed Apr 1, 2014 · Spouse
- Apr 1, 2014$1K–$15K
$1K–$15K · Traded Mar 27, 2014 · disclosed Apr 1, 2014 · Spouse
Got $15K from the company’s PAC
Recent Congress trades in BIIB
- Oct 7, 2026$1K–$15K
Rep. Maria Elvira Salazar (R-FL-27)
$1K–$15K · Traded Sep 24, 2026 · disclosed Oct 7, 2026
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 11, 2026 · disclosed Oct 7, 2026 · Dependent
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Sep 1, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
$1K–$15K · Traded Aug 18, 2026 · disclosed Sep 1, 2026
Got $5K from the company’s PAC - Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jul 7, 2026$15K–$50K
Rep. Maria Elvira Salazar (R-FL-27)
$15K–$50K · Traded Jun 2, 2026 · disclosed Jul 7, 2026
- Jul 2, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Jun 5, 2026 · disclosed Jul 2, 2026
- Jun 8, 2026$1K–$15K
Rep. Maria Elvira Salazar (R-FL-27)
$1K–$15K · Traded May 12, 2026 · disclosed Jun 8, 2026
Company context for BIIB
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
BIIB: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
BIIB: Financial results
Filed 8-K for an event or period dated 2026-10-28. Financial results.
1 congressional household disclosed purchases in the past 90 days. See the trades
BIIB: third_quarter 2026 lobbying report
Issues related to Alzheimer's Disease and treatment. Amyotrophic lateral sclerosis (ALS), Lou Gehrigs Disease and treatment and Lupus. Issues related to the budget and appropriations process Issues related to rare diseases and treatment. Issues related to Mental Health treatment. Issues related to maternal health. Issues related to the budget and appropriations process
Public: Oct 20, 2026, 11:09 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.